Immediate Impact

1 by Nobel laureates 51 standout
Sub-graph 1 of 24

Citing Papers

Bacterial siderophores: diversity, uptake pathways and applications
2024 Standout
The Rise of Boron-Containing Compounds: Advancements in Synthesis, Medicinal Chemistry, and Emerging Pharmacology
2024 Standout
2 intermediate papers

Works of Mya Thein being referenced

Outcome of older patients with acute myeloid leukemia
2013
A Phase I study of the novel ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) in combination with the nucleoside analog fludarabine for patients with refractory acute leukemias and aggressive myeloproliferative disorders
2007

Author Peers

Author Last Decade Papers Cites
Mya Thein 221 102 104 141 12 437
Phillip J. DeChristopher 108 103 55 53 29 505
JoLyn Turner 59 114 82 110 9 385
Alice Melão 87 152 45 90 13 373
Michael Katzenstein 142 101 53 54 6 417
Michael Steinberg 189 95 62 138 21 460
Alberto Santagostino 188 224 73 99 17 464
Evangelia Vlachodimitropoulou 156 38 78 40 19 485
Suzanne Hauffe 134 45 139 154 11 396
Edward H. Reisner 64 58 50 87 23 399
D C Doll 102 116 60 85 14 464

All Works

Loading papers...

Rankless by CCL
2026